, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Biomarkers Definitions Working Group, vol.69, pp.89-95, 2001.
, Biomarkers in Nephrology. Am J Kidney Dis, vol.62, pp.165-178, 2013.
Biomarkers in Kidney Disease, 2011. ,
Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy, Clin J Am Soc Nephrol, vol.6, pp.2846-2853, 2011. ,
Low-and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study, Nephrol Dial Transplant, vol.28, pp.137-146, 2013. ,
Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-?-D-glucosaminidase in glomerulonephritis, J Nephrol, 2014. ,
Biomarkers in glomerular diseases : putting the cart before the wheel?, Nephrol Dial Transplant, vol.30, pp.885-890, 2015. ,
Membranous nephropathy: the start of a paradigm shift, Curr Opin Nephrol Hypertens, vol.21, pp.203-210, 2012. ,
Podocyte-secreted angiopoietinlike-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome, Nat Med, vol.17, pp.117-122, 2011. ,
Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shaken, J Am Soc Nephrol, vol.25, pp.1611-1613, 2014. ,
Abatacept in B7-1-positive proteinuric kidney disease, N Engl J Med, vol.369, pp.2416-2423, 2013. ,
Markers of and risk factors for the development and progression of diabetic kidney disease, Am J Kidney Dis, vol.63, pp.39-62, 2014. ,
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis, Arthritis Rheum, vol.64, pp.2687-2697, 2012. ,
The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism-individual patient variability in disease presentation, course and response to therapy, Nephrol Dial Transplant, vol.30, pp.892-898, 2015. ,
Ten-year advances in immunopathology of glomerulonephritis: translated into patients' care or lost in translation?, Semin Immunopathol, vol.36, pp.377-379, 2014. ,
Risk HLA-DQA1 and PLA (2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, vol.364, pp.616-626, 2011. ,
M-type phospholipase A2 receptor as target antigen in idiopathic MN, N Engl J Med, vol.361, pp.11-21, 2009. ,
Membranous nephropathy: recent pathophysiological advances leading to a paradigm shift in patient's care, Lancet, 2015. ,
Anti-PLA2R antibody titer predicts post-rituximab outcome of membranous nephropathy, J Am Soc Nephrol, vol.25, pp.1786-1798, 2014. ,
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, pp.2277-2287, 2014. ,
The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine, Am J Pathol, vol.183, pp.1075-1083, 2013. ,
Urinary biomarkers: alone are they enough?, J Am Soc Nephrol, 2014. ,